OR
Orgenesis Inc.
ORGS · OTC
$0.59 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.78M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
0 /100
Expensive P/S 10.91x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 58.93%
EPS growth N/A
FCF growth N/A
Profitability
0 /100
Weak Gross margin 1,080.19%
Net margin 10,445.50%
FCF margin 3,194.91%
Quality
1 /100
Poor ROIC 3,180.09%
ROA 380.44%
Asset turnover 0.04x
Debt
0 /100
High Current ratio 0.25x
Int. coverage -28.74x
Debt/Equity N/A
Stability
1 /100
Unstable Beta 3.14x
Rev. volatility 243.34%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ORGS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Vered Caplan
Employees
77
Headquarters
Germantown
Nadchodzące wydarzenia
11 LIS
Earnings
Upcoming earnings report